Your questions about the third dose, answered.
September 20, 2021, was technically the first day that some people who received their second shot of the Pfizer Covid-19 vaccine were eligible for a booster in the U.S.
That being said, you probably have questions about boosters — especially because not every expert is advocating for widespread availability.
It’s still unclear if people with few health risks need boosters to stay protected — but a third shot should reinforce the body’s defenses.
Only those aged 65 and older and people who are at high risk for severe Covid-19 can get a third shot of the Pfizer vaccine.
On September 17, 2021, an FDA advisory panel announced there was insufficient evidence to recommend Pfizer boosters to everyone aged 16 and older.
A decision has not yet been made on Moderna boosters.
Yes, it’s the same formula and the same dosage.
Only Pfizer. Both Moderna and a J&J booster are on the way.
Johnson & Johnson announced on September 21, 2021, that trial data from its booster shot showed a strong immune response in people of all ages.
Right now, the World Health Organization does not recommend it, but the CDC says it’s fine as long as you’re mixing two mRNA vaccines.
On the other hand, some studies are starting to show that some combinations might actually elicit higher immune responses than taking two doses of the same shot. This suggests switching it up may be better.
For some. It’s similar to the first dose(s) of the vaccines.
Side-effects include soreness or swelling at the injection site, headaches, or a mild fever. It’s normal to not feel any side effects, too.
It depends on your risk factors. But recent studies do show that initial vaccination is still effective against Delta and other variants.
That’s been a subject of debate among the CDC, FDA, and WHO. Recent data shows they work — but equity is another question.
The richest countries, including the U.S., have plentiful access to vaccines. Much of the world doesn’t.
Scientists agree that it’s more important to get first and second doses to those waiting for vaccines — rather than prioritize third doses for others.